American Society of Clinical Oncology (ASCO)

JCO Precision Oncology Conversations

Health EN ↓ 83 episodes

JCO Precision Oncology Conversations podcasts features discussions with leading authors of JCO Precision Oncology articles, hosted by Dr. Abdul Rafeh Naqash. Join our experts in engaging conversations as they examine groundbreaking research in the world of precision oncology and learn how these advancements are redefining treatment protocols. The year's fellows summarize the top JCO Precision Oncology articles in the series, JCO PO Article Insights.

Be sure to visit the podcast's website and support the creator: ascopubs.org

Author

American Society of Clinical Oncology (ASCO)

Category

Health

Podcast website

ascopubs.org

Latest episode

Nov 3, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

JCO PO Article Insights: MCED Test Preferentially Detects High-Grade Prostate Cancers 25.09.2024

In this JCO Precision Oncology Article Insights episode, Mitchell Elliot summarizes an editorial: " A Targeted Methylation–Based Multicancer Early Detection Blood Test Preferentially Detects High-Grade Prostate Cancer While Minimizing Overdiagnosis of Indolent Disease " by Dr. Brandon A. Mahal, et al. published on August 29, 2024.   TRANSCRIPT Mitchell Elliott: Hello and welcome to JCO Precision O...

Molecular Characteristics of Early-Onset Biliary Tract Cancer 18.09.2024

JCO PO author Dr. Alok A. Khorana, MD, FASCO, Professor of Medicine, Cleveland Clinic and Case Comprehensive Cancer Center, shares insights into the JCO PO article, " Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract Cancers ." Host Dr. Rafeh Naqash and Dr. Khorana discuss how multiomic analysis shows higher FGFR2 fusions and immunotherapy...

JCO PO Article Insights: Publication Trends in JCO Precision Oncology 28.08.2024

In this JCO Precision Oncology Article Insights episode, Miki Horiguchi summarizes an editorial: " Expanding the Reach of Personalized Medicine in Cancer Care: Current Progress and Future Directions of JCO Precision Oncology " by Dr. Yushu Shi et al. published on May 30, 2024. TRANSCRIPT Hello and welcome to  JCO Precision Oncology Article Insights . I'm your host Miki Horiguchi, an ASCO Journals...

CCR Score to Predict ADT Benefit in Men with Prostate Cancer 21.08.2024

JCO PO author Dr. Jonathan D. Tward, M.D., Ph. D., FASTRO, at the HCI Genitourinary Cancers Center and the Huntsman Cancer Institute at the University of Utah, shares insights into his JCO PO article, " Using the Cell-Cycle Risk Score to Predict the Benefit of Androgen-Deprivation Therapy Added to Radiation Therapy in Patients With Newly Diagnosed Prostate Cancer. " Host Dr. Rafeh Naqash and Dr. T...

JCO PO Article Insights: Statistical Considerations for Biomarker-Driven Oncology Clinical Trials 31.07.2024

In this JCO Precision Oncology Article Insights episode, Miki Horiguchi summarizes two articles: " Biomarker-Driven Oncology Trial Design and Subgroup Characterization: Challenges and Potential Solutions " by Wang, et al. published on June 7, 2024, and " Biomarkers in Oncology: Complexities in Biomarker-Driven Studies and Statistical Analysis " by Uno, et al. published on July 22, 2024. TRANSCRIPT...

JCO PO Article Insights: Role of ctDNA in Appendiceal Cancer 26.06.2024

In this JCO Precision Oncology Article Insights episode, Fergus Keane provides a summary on " Multi-Institutional Study Evaluating the Role of Circulating Tumor DNA in the Management of Appendiceal Cancers " by Belmont, et al published on May 9th, 2024. TRANSCRIPT  Fergus Keane: Hello and welcome to JCO Precision Oncology Article Insights . I'm your host, Fergus Keane, an ASCO editorial fellow. To...

PD-L1 Assay Concordance in Gastric Cancer 19.06.2024

JCO PO author Dr. Samuel J. Klempner shares insights into his JCO PO article, "PD-L1 Immunohistochemistry in Gastric Cancer: Comparison of Combined Positive Score and Tumor Area Positivity across 28-8, 22C3, and SP263 assays". Host Dr. Rafeh Naqash and Dr. Klempner discuss assessing the analytical comparability of three commercially available PD-L1 assays and two scoring algorithms used to assess...

JCO PO Article Insights: Serial Post Operative ctDNA Predicts Poor Breast Cancer Outcome 29.05.2024

In this JCO Precision Oncology Article Insights episode, Mitchell Elliot provides a summary on " Serial Postoperative Circulating Tumor DNA Assessment Has Strong Prognostic Value During Long-Term Follow-Up in Patients With Breast Cancer " by Shaw, et al published on May 1st, 2024. TRANSCRIPT The guest on this podcast episode has no disclosures to declare.  Mitchell Elliott: Hello and welcome to th...

Phase II Study of Erdafitinib in Tumors with FGFR Amplifications and Mutations or Fusions 15.05.2024

JCO PO author Dr. Jun Gong shares insights into his JCO PO articles, " Phase II Study of Erdafitinib in Patients with Tumors with FGFR Amplifications: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Sub-protocol K1 " and " Phase II Study of Erdafitinib in Patients with Tumors with FGFR Mutations or Fusions: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Sub-protocol K2 ". Host Dr. Rafeh...

JCO PO Article Insights: Web-Based Pretest Genetic Education for Prostate Cancer Germline Testing 24.04.2024

In this JCO PO Article Insights episode, Miki Horiguchi provides a summary on the article, " TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline Testing and explains what a non-inferiority trial is.  TRANSCRIPT Miki Horiguchi:  Hello and welcome to JCO Precision Oncology Article Insights . I'm your...

Liquid Biopsy of Lung Cancer Before Pathological Diagnosis Is Associated With Shorter Time to Treatment 17.04.2024

JCO PO author Dr. Christian Rolfo shares insights into his JCO PO article, " Liquid Biopsy of Lung Cancer Before Pathological Diagnosis Is Associated With Shorter Time to Treatment ." Host Dr. Rafeh Naqash and Dr. Rolfo discuss how early liquid biopsy in aNSCLC in parallel with path dx is associated with shorter time to treatment. TRANSCRIPT   Dr. Rafeh Naqash: Hello and welcome to JCO Precision O...

JCO PO Article Insights: Microsatellite Instability as a Biomarker in Clinical Practice 27.03.2024

In this JCO PO Article Insights episode, Fergus Keane provides a summary on " Microsatellite Instability Is Insufficiently Used as a Biomarker for Lynch Syndrome Testing in Clinical Practice ", by Papadopoulou, et al published January 25, 2024 TRANSCRIPT The guest on this podcast episode has no disclosures to declare. Fergus Keane: Hello and welcome to JCO Precision Oncology Article Insights . I'm...

Recommendations for the Equitable and Widespread Implementation of Liquid Biopsy 20.03.2024

JCO PO authors Lauren C. Leiman and Dr. Emma Alme share insights into their JCO PO article, " Recommendations for the Equitable and Widespread Implementation of Liquid Biopsy for Cancer Care ". Host Dr. Rafeh Naqash and guests discusses increasing access to liquid biopsy for cancer, reviewing the barriers and examining the proposed solutions. TRANSCRIPT Dr. Rafeh Naqash: Hello and welcome to JCO P...

JCO PO Article Insights: Prediction of Adjuvant Pertuzumab Benefit by 80-GS 28.02.2024

In this JCO Precision Oncology Article Insights episode, Mitchell Elliot provides a summary on " Prediction of Benefit From Adjuvant Pertuzumab by 80-Gene Signature in the APHINITY (BIG 4-11) Trial ," by Krop, et al published on January 18th, 2024. TRANSCRIPT Mitchell Elliott: Hello and welcome to JCO Precision Oncology Article Insights . I'm your host, Mitchell Elliott, an ASCO Journal Editorial...

MultiCancer Detection Test Performance in Symptomatic Individuals 21.02.2024

JCO PO author Dr. Eric Klein shares insights into his JCO PO article, " Performance of a Cell-Free DNA-Based Multi-Cancer Detection Test in Individuals Presenting with Symptoms Suspicious for Cancers " Host Dr. Rafeh Naqash and Dr. Klein discuss how a multi-cancer detection test may facilitate workup and stratification of cancer risk in symptomatic individuals. TRANSCRIPT Dr. Rafeh Naqash: Hello a...

JCO PO Article Insights: Diverse Study Samples in Clinical Trials 31.01.2024

In this JCO Precision Oncology Article Insights episode, Miki Horiguchi provides a summary on " Clinical Trial Diversity: A Bend in the Arc Towards Justice ", by Tannenbaum, et al published on September 19, 2023 in JCO Precision Oncology. The editorial discusses the need for inclusion of under-represented groups in clinical trials. See the accompanying Original Report, " Representativeness of Pati...

Tumor Mutational Burden and Advanced Pancreatic Cancer 24.01.2024

JCO PO author Dr. Amit Mahipal shares insights into his JCO PO article, " Tumor Mutational Burden in Real-world Patients with Pancreatic Cancer: Genomic Alterations and Predictive Value for Immune Checkpoint Inhibitor Effectiveness ." Host Dr. Rafeh Naqash and Dr Mahipal discuss real world evidence of immune checkpoint inhibitors in pancreatic ductal adenocarcinoma. TRANSCRIPT Dr. Rafeh Naqash: We...

Representativeness of Lung-MAP Participants 20.12.2023

  JCO PO author Dr. Mary Redman shares insights into her JCO PO article, " Representativeness of Patients Enrolled in the Lung Cancer Master Protocol (Lung-MAP) " Host Dr. Rafeh Naqash and Dr. Redman discuss the background of LungMAP and how it was developed to accelerate drug development and biomarker-driven therapies in lung cancer. Dr. Redman shares the initiatives undertaken to increase partic...

Perspectives on Universal Germline Testing for Colorectal Cancer 22.11.2023

JCO PO author Dr. Sanjeevani Arora shares insights into her JCO PO article, " Exploring Stakeholders' Perspectives on Implementing Universal Germline Testing for Colorectal Cancer: Findings from a Clinical Practice Survey " Host Dr. Rafeh  Naqash  and Dr. Arora discuss  germline genetic testing for all colorectal cancer (CRC) patients and  advantages and barriers of implementing universal germline...

Outcomes of the IMMray PanCan-d Test in High-Risk Individuals 26.10.2023

JCO PO author Dr. Bryson Katona shares insights into his JCO PO article, "Outcomes of the IMMray PanCan-dTM test in High-Risk Individuals Undergoing Pancreatic Surveillance: Pragmatic Data and Lessons Learned." Host Dr. Rafeh Naqash and Dr. Katona discuss IMMray PanCan-d:  A Blood-based Test for Early Detection of Pancreatic Cancer. TRANSCRIPT Dr. Rafeh Naqash: Hello and welcome to JCO Precision O...

Implementation of the Maine Cancer Genomics Initiative 20.09.2023

JCO PO author Dr. Jens Rueter Chief Medical Officer at The Jackson Laboratory and Medical Director of the Maine Cancer Genomics Initiative, shares insights into his JCO PO article, " The Maine Cancer Genomics Initiative: Implementing a Community Cancer Genomics Program Across an Entire Rural State ." Host Dr. Rafeh Naqash and Dr. Rueter discuss this successful initiative for patient s and its impl...

Pertuzumab + Trastuzumab in Lung Cancer with ERBB2 Alterations 16.08.2023

JCO PO author Dr. Apar K. Ganti shares insights into his JCO PO article, "Pertuzumab Plus Trastuzumab in Patients With Lung Cancer With ERBB2 Mutation or Amplification: Results From the Targeted Agent and Profiling Utilization Registry Study." Host Dr. Rafeh Naqash and Dr. Ganti discuss clinical decision-making regarding biopsy; HER2 amplification, mutation, and targeted therapy; drug combinations...

MMR-P Colorectal Cancer in Lynch Syndrome 19.07.2023

JCO PO author Dr. Alicia Latham shares insights into her JCO PO article, "Prevalence and Clinical Implications of Mismatch Repair-Proficient Colorectal Cancer in Patients With Lynch Syndrome." Host Dr. Rafeh Naqash and Dr. Latham discuss microsatellite instability-high status as well as familial risk and testing. Click here to read the article! TRANSCRIPT Dr. Rafeh Naqash: Hello, and welcome to JC...

Real-World NTRK Fusions and TRK Inhibitors in Veterans 21.06.2023

JCO PO authors Dr. Michael J. Kelley and Dr. Katherine I. Zhou share insights into their JCO PO article, "Real-world Experience With Neurotrophic Tyrosine Receptor Kinase Fusion–positive Tumors and Tropomyosin Receptor Kinase Inhibitors in Veterans." Host Dr. Rafeh Naqash, Dr. Kelley, and Dr. Zhou discuss the robust Veterans Affairs (VA) National Precision Oncology Program (NPOP), accurate identif...

Larotrectinib for TRK Fusion - Positive Lung Cancer 17.05.2023

JCO PO author Alexander E. Drilon, MD, shares insights into his article, "Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase Fusion–Positive Lung Cancers" and the article's findings of the activity of larotrectinib in patients with advanced lung cancer harboring NTRK gene fusions. Host Dr. Rafeh Naqash and Dr. Drilon discuss drug development, testing for fusions, res...

Listen to the JCO Precision Oncology Conversations podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.